Rosetta Genomics (ROSGQ) Stock Statistics & Valuation Metrics

Rosetta Genomics has a market cap or net worth of $593.00. The enterprise value is ―.

Rosetta Genomics has 5,930,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Rosetta Genomics’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Rosetta Genomics is ―. Rosetta Genomics’s PEG ratio is ―.

In the last 12 months, Rosetta Genomics had revenue of 9.23M and earned -16.23M in profits. Earnings per share was -9.31.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Rosetta Genomics pays an annual dividend of ―, resulting in a dividend yield of ―

Rosetta Genomics upcoming earnings date is ―, ―.

Rosetta Genomics as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Rosetta Genomics has paid -34.00K in taxes.

Rosetta Genomics EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Rosetta Genomics has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Rosetta Genomics is ―, which is 11.43% higher than the current price. The consensus rating is ―